Pantoprazole sodium hydrate(CAS: 164579-32-2)

Pantoprazole sodium hydrate (CAS: 164579-32-2) falls under the GHS classification as a medicine and is subject to REACH regulations. It must comply with FDA and EPA guidelines for pharmaceuticals. Proper labeling, storage, and handling practices are required to ensure safety and regulatory compliance.

Alternative reagents such as omeprazole or esomeprazole can be used as alternatives to Pantoprazole sodium hydrate (CAS: 164579-32-2) in synthesis. Isomers and analogs like pantoprazole dihydrate or pantoprazole monohydrate are also available and can serve as suitable substitutes.

The market for Pantoprazole sodium hydrate (CAS: 164579-32-2) is primarily driven by its use in treating gastrointestinal disorders. Research trends focus on its efficacy and safety, as well as exploring new formulations and delivery systems. Emerging studies also look into its potential in other therapeutic areas.

Waste containing Pantoprazole sodium hydrate (CAS: 164579-32-2) should be collected in appropriate containers and disposed of via incineration or through professional waste management services. Environmental precautions include proper labeling and minimizing exposure to ensure safety and compliance with local regulations.